Abstract: Provided herein are salt forms of macrocyclic protein kinase inhibitors, pharmaceutical compositions containing the same, methods of making and using these compounds and compositions to treat proliferative disease mediated by kinase activity.
Type:
Grant
Filed:
February 4, 2011
Date of Patent:
September 1, 2015
Assignee:
Tragara Pharmaceuticals, Inc.
Inventors:
Robert K. Mansfield, Tracy Lawhon, Brian Dymock
Abstract: Described herein are compositions and methods for using these compositions in the treatment of cancer, tumors, and tumor-related disorders in a subject.
Type:
Application
Filed:
June 21, 2012
Publication date:
April 4, 2013
Applicant:
Tragara Pharmaceuticals, Inc.
Inventors:
Thomas M. Estok, Sara L. Zaknoen, Robert K. Mansfield, Tracy Lawhon
Abstract: Described herein are compositions and methods for using these compositions in the treatment of cancer, tumors, and tumor-related disorders in a subject.
Type:
Grant
Filed:
July 11, 2008
Date of Patent:
August 21, 2012
Assignee:
Tragara Pharmaceuticals, Inc.
Inventors:
Thomas M. Estok, Sara L. Zaknoen, Robert K. Mansfield, Tracy Lawhon
Abstract: Described herein are compositions and methods for using these compositions in the treatment of cancer, tumors, and tumor-related disorders in a subject.
Type:
Application
Filed:
September 23, 2008
Publication date:
January 19, 2012
Applicant:
Tragara Pharmaceuticals, Inc.
Inventors:
Thomas M. Estok, Sara L. Zaknoen, Robert K. Mansfield, Tracy Lawhon
Abstract: Described herein are compositions and methods for using these compositions in the treatment of cancer, tumors, and tumor-related disorders in a subject.
Abstract: Described herein are compositions and methods for using these compositions in the treatment of cancer, tumors, and tumor-related disorders in a subject.
Type:
Application
Filed:
July 11, 2008
Publication date:
January 15, 2009
Applicant:
Tragara Pharmaceuticals, Inc.
Inventors:
Thomas M. Estok, Sara L. Zaknoen, Robert K. Mansfield, Tracy Lawhon